Clarithromycin description, usages, side effects, indications, overdosage, supplying and lots more!

Menu
Search

Clarithromycin

REMEDYREPACK INC.


FULL PRESCRIBING INFORMATION: CONTENTS*




FULL PRESCRIBING INFORMATION

CLARITHROMYCIN DESCRIPTION


Clarithromycin







CLINICAL PHARMACOLOGY


PHARMACOKINETICS





















MICROBIOLOGY











































































INDICATIONS & USAGE





















Prophylaxis:



CLARITHROMYCIN CONTRAINDICATIONS





WARNINGS








PRECAUTIONS













DRUG INTERACTIONS

























CARCINOGENESIS & MUTAGENESIS & IMPAIRMENT OF FERTILITY
















PREGNANCY





NURSING MOTHERS



PEDIATRIC USE



GERIATRIC USE



CLARITHROMYCIN ADVERSE REACTIONS



















OVERDOSAGE




DOSAGE & ADMINISTRATION
























HOW SUPPLIED




















CLINICAL STUDIES

Mycobacterial Infections






Clarithromycin















Treatment:







MAC bacteremia:




Clinically significant disseminated MAC Disease:

















Otitis Media











Duodenal Ulcer Associated with H. pylori Infection













































ANIMAL PHARMACOLOGY & OR TOXICOLOGY



REFERENCES







PACKAGE LABEL.PRINCIPAL DISPLAY PANEL SECTION














Clarithromycin

Clarithromycin

Clarithromycin

Clarithromycin TABLET

Product Information

Product Type Human prescription drug label Item Code (Source) NDC:49349-275(NDC:63304-725)
Route of Administration ORAL DEA Schedule

Active Ingredient/Active Moiety

Ingredient Name Basis of Strength Strength
CLARITHROMYCIN CLARITHROMYCIN 250 mg

Inactive Ingredients

Ingredient Name Strength
D&C YELLOW NO. 10
SILICON DIOXIDE
CROSCARMELLOSE SODIUM
hydroxypropyl cellulose
HYPROMELLOSES
MAGNESIUM STEARATE
cellulose, microcrystalline
povidone
propylene glycol
SHELLAC
STEARIC ACID
talc
titanium dioxide

Product Characteristics

Color Size Imprint Code Shape
yellow 16 mm RX;725 OVAL

Packaging

# Item Code Package Description Marketing Start Date Marketing End Date
1 NDC:49349-275-02 30 in 1 BLISTER PACK

Marketing Information

Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
ANDA ANDA065174 2011-06-01


PLEASE, BE CAREFUL!
Be sure to consult your doctor before taking any medication!
Copyright © 2014. drugs-library.com. All rights reserved. Information on drugs-library.com is provided for educational purposes only and is not to be used for medical advice, diagnosis or treatment.
Support info@drugs-library.com.